From: Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
Characteristics | Number of patients |
---|---|
Median age (years) | 62 (42–85) |
Sex (male/female) | 25/45 (36%/64%) |
Asbestos exposure | 57 (81.4%) |
Mesian BMI | 22.79 (15.23–31.49) |
Median survival (months) | 10 (1–42) |
Treatment | |
Intraperitoneal chemotherapy with cisplatin | 35 (50%) |
Cisplatin + pemetrexed | 14 (20%) |
Untreated | 21 (30%) |
Symptoms | |
abdominal distension | 50 (71.4%) |
abdominal pain | 25 (35.8%) |
Histology type | |
Epithelioid | 50 (71.4%) |
Biphasic + sarcomatoid | 20 (28.6%) |
NLR (range) | 0.69–18.46 |
NLR ≥ 3 | 35 (50%) |
NLR < 3 | 35 (50%) |
ALB (range) | 23–48 g/L |
Normal albumin (ALB ≥ 35 g/L) | 33 (47.1%) |
Hypoalbuminemia (ALB < 35 g/L) | 37 (52.9%) |